Related Experiment Video
Updated: May 1, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
[New oral anticoagulants in perioperative medicine]
1Institut für Transfusionsmedizin und Hämostaseologie, Klinikum Augsburg, Augsburg, Deutschland.
Abstract:
New oral anticoagulants (NOAC) inhibit factor Xa (Stuart-Prower factor) or factor IIa (thrombin) and are alternatives to vitamin K antagonists. Perioperative indications are deep vein thrombosis prophylaxis for prosthetic hip and knee replacement, therapeutic anticoagulation for deep vein thrombosis as well as the prophylaxis of stroke for patients with atrial fibrillation. Patients on NOACs pose multiple perioperative challenges for all medical disciplines involved. For non-emergency surgery, patients should be evaluated by an anesthesiolgist as early as possible to assess an optimal appointment for surgery and bridging strategy. Management of emergency procedures for patients on NOACs requires an interdisciplinary approach. The individual risk for uncontrolled bleeding versus the urgency for surgery needs to be evaluated on an individual basis. The determination of drug serum levels enables a rough estimation of anticoagulant activity. Emergency procedures in coagulopathy due to active bleeding are treated with the unspecific administration of blood products and coagulation factor concentrates.
Insights
New oral anticoagulants (NOACs) require careful perioperative management due to bleeding risks. Early anesthesiologist evaluation and interdisciplinary approaches are crucial for safe surgical planning and emergency procedures.
Area of Science:
- Pharmacology and Hematology
- Anesthesiology and Perioperative Medicine
Context:
- New oral anticoagulants (NOACs) are increasingly used as alternatives to vitamin K antagonists for various indications.
- Perioperative management of patients on NOACs presents significant challenges across medical disciplines.
- Indications include deep vein thrombosis prophylaxis, therapeutic anticoagulation, and stroke prophylaxis in atrial fibrillation.
Purpose:
- To outline the perioperative challenges associated with NOACs.
- To emphasize the need for early anesthesiologist evaluation for non-emergency surgeries.
- To highlight the importance of an interdisciplinary approach for managing emergency procedures.
Summary:
- NOACs inhibit factor Xa or factor IIa, posing challenges for perioperative care.
- Non-emergency surgery requires early anesthesiologist consultation for optimal scheduling and bridging strategies.
- Emergency procedures necessitate individualized risk assessment (bleeding vs. urgency) and may involve drug serum level determination.
Impact:
- Informed perioperative strategies for patients on NOACs can mitigate bleeding risks.
- Facilitates safer surgical planning and execution for patients requiring anticoagulation.
- Guides management of coagulopathy during emergency procedures, including the use of blood products and factor concentrates.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Aneurysm IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Cardiomyopathy VII: Pre and Post Operative Nursing Management

